Abiopharma

News list

FERGUSON III MARK E 🟡 adjusted position in 0 shares of VSE CORP (VSEC) Transaction Date: Aug 11, 2026 | Filing ID: 347393

Full text

News bot Aug. 12, 2026, 11:32 p.m.
🔍 FERGUSON III MARK E (Executive)

Company: VSE CORP (VSEC)

Report Date: 2026-08-11
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 350
- Total shares sold: 350
Detailed Transactions and Holdings:
- Sold 350 shares of Common Stock, par value $.05 (Direct)
  Date: 2026-08-11 | Code: G | equity_swap_involved: false | shares_owned_after: 17,205.00 | transaction_form_type: 4 | Footnotes: F1
- Acquired 350 shares of Common Stock, par value $.05 (Direct)
  Date: 2026-08-11 | Code: G | equity_swap_involved: false | shares_owned_after: 350.00 | transaction_form_type: 4
Footnotes:
- F1: On August 11, 2026, the reporting person transferred 350 shares of VSE common stock from the Mark E. Ferguson III Revocable Trust to the Laure D. Ferguson Revocable Trust at no consideration. The reporting person and his spouse are co-trustees of both the Mark E. Ferguson III Revocable Trust and the Laure D. Ferguson Revocable Trust, and the reporting person's two children are the sole beneficiaries of each trust.